Enterprise Value
1.668B
Cash
296.3M
Avg Qtr Burn
-79.19M
Short % of Float
25.30%
Insider Ownership
4.51%
Institutional Own.
88.79%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
REC-2282 Details Neurofibromatosis Type 2-mutated meningiomas | Phase 2/3 Data readout | |
REC-4881 Details Familial Adenomatous Polyposis | Phase 2 Data readout | |
REC-4881 Details Cancer | Phase 2 Data readout | |
REC-994 Details Cerebral cavernous malformation | Phase 2 Data readout | |
REC-3964 Details Clostridium difficile Colitis | Phase 2 Initiation | |
RBM39 Details Cancer | IND Submission | |
REC-3599 Details GM2 gangliosidosis | Failed Discontinued |